Sign in
4

Changes in Ownership

HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001209191-21-046786

EVP, Drug Development gave up 433 shares (to pay taxes)

  • EVP, Drug Development acquired 1,250 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
MANHARD KIMBERLY EVP, Drug Development 2021-07-13 Option exercise +1,250 2,884 D
MANHARD KIMBERLY EVP, Drug Development 2021-07-13 Shares withheld for taxes −433 $13.48 $5,837 2,451 D
Derivatives
MANHARD KIMBERLY EVP, Drug Development 2021-07-13 Option exercise · Restricted Stock Units −1,250 16,250 D
Loading xslF345X03/doc4.xml…